100 related articles for article (PubMed ID: 6146691)
1. Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures.
Govoni S; Petkov VV; Montefusco O; Missale C; Battaini F; Spano PF; Trabucchi M
J Pharm Pharmacol; 1984 Jul; 36(7):458-60. PubMed ID: 6146691
[TBL] [Abstract][Full Text] [Related]
2. Subchronic methamphetamine treatment selectively attenuates apomorphine-induced decrease in 3,4-dihydroxyphenylacetic acid level in mesolimbic dopaminergic regions.
Watanabe H
Life Sci; 1985 Dec; 37(24):2319-25. PubMed ID: 4068904
[TBL] [Abstract][Full Text] [Related]
3. Altered responsiveness of regional brain dopamine and DOPAC levels to systemic administration of quinpirole, a dopamine D2 agonist, in DOCA/NaCl-hypertensive rats.
Chen YF; Jin HK; Gist R; Oparil S
Brain Res; 1987 Jun; 413(1):15-22. PubMed ID: 2954616
[TBL] [Abstract][Full Text] [Related]
4. Differential changes in DOPAC levels in the hippocampal formation, septum and striatum of the rat induced by acute and repeated neuroleptic treatment.
Scatton B
Eur J Pharmacol; 1981 May; 71(4):499-503. PubMed ID: 6113973
[TBL] [Abstract][Full Text] [Related]
5. Biphasic effects of m-chlorophenyl-piperazine on 3,4-dihydroxyphenylacetic acid concentration in rat brain.
Fuller RW; Snoddy HD
Res Commun Chem Pathol Pharmacol; 1977 Jul; 17(3):551-4. PubMed ID: 897345
[TBL] [Abstract][Full Text] [Related]
6. Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs.
Westerink BH; Korf J
Eur J Pharmacol; 1976 Aug; 38(2):281-91. PubMed ID: 954842
[TBL] [Abstract][Full Text] [Related]
7. Tolerance to haloperidol-induced increases in dopamine metabolites: fact or artifact?
Finlay JM; Jakubovic A; Fu DS; Fibiger HC
Eur J Pharmacol; 1987 May; 137(1):117-21. PubMed ID: 3609130
[TBL] [Abstract][Full Text] [Related]
8. Monoamine content in rat brain during carcinogenesis and the influence of the CNS drugs piracetam and imipramine.
von Metzler A; Nitsch C
Naturwissenschaften; 1985 Oct; 72(10):542-3. PubMed ID: 2415828
[No Abstract] [Full Text] [Related]
9. A radioenzymatic method to measure picogram amounts of dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) in small samples of brain tissue.
Argiolas A; Fadda F
Experientia; 1978 Jun; 34(6):739-41. PubMed ID: 658286
[TBL] [Abstract][Full Text] [Related]
10. Tail-pinch stress increases extracellular DOPAC levels (as measured by in vivo voltammetry) in the rat nucleus accumbens but not frontal cortex: antagonism by diazepam and zolpidem.
D'Angio M; Serrano A; Rivy JP; Scatton B
Brain Res; 1987 Apr; 409(1):169-74. PubMed ID: 3580866
[TBL] [Abstract][Full Text] [Related]
11. Regional effects of amphetamine, cocaine, nomifensine and GBR 12909 on the dynamics of dopamine release and metabolism in the rat brain.
Karoum F; Chrapusta SJ; Brinjak R; Hitri A; Wyatt RJ
Br J Pharmacol; 1994 Dec; 113(4):1391-9. PubMed ID: 7889297
[TBL] [Abstract][Full Text] [Related]
12. Elevation of 3, 4-dihydroxyphenylacetic acid concentrations in rat brain and stimulation of prolactin secretion by fenfluramine: evidence for antagonism at dopamine receptor sites.
Fuller RW; Perry KW; Clemens JA
J Pharm Pharmacol; 1976 Aug; 28(8):643-4. PubMed ID: 11315
[No Abstract] [Full Text] [Related]
13. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
Westerink BH; Korf J
Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
[TBL] [Abstract][Full Text] [Related]
14. Repeated atypical neuroleptic administration: effects on central dopamine metabolism monitored by in vivo voltammetry.
Maidment NT; Marsden CA
Eur J Pharmacol; 1987 Apr; 136(2):141-9. PubMed ID: 3595718
[TBL] [Abstract][Full Text] [Related]
15. Chronic antidepressant administration fails to attenuate apomorphine-induced decreases in rat striatal dopamine metabolites.
Diggory GL; Buckett WR
Eur J Pharmacol; 1984 Oct; 105(3-4):257-63. PubMed ID: 6510470
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous radioenzymatic assay of dopamine and dihydroxyphenylacetic acid: an index of in vivo dopamine release.
Cheng CH; Wooten GF
J Pharmacol Methods; 1981 Mar; 5(2):165-73. PubMed ID: 7230840
[TBL] [Abstract][Full Text] [Related]
17. Behavioural effects of long-term administration of fencamfamine: neurochemical implications.
Planeta CS; Scavone C; De Lucia R; Aizenstein ML
Gen Pharmacol; 1987; 18(4):347-9. PubMed ID: 3609692
[TBL] [Abstract][Full Text] [Related]
18. Decreased tuberoinfundibular and pituitary dopamine and dihydroxyphenylacetic acid concentrations in rats with estrogen-induced pituitary tumors.
Di Paolo T; Daigle M; Barden N
Neurosci Lett; 1985 Mar; 54(2-3):251-6. PubMed ID: 3991064
[TBL] [Abstract][Full Text] [Related]
19. Rat dopaminergic function in the retina during aging.
Riccardi F; Covelli V; Spano PF; Govoni S; Trabucchi M
Neurobiol Aging; 1981; 2(3):229-31. PubMed ID: 6273758
[TBL] [Abstract][Full Text] [Related]
20. 3,4-dihydroxyphenylacetic acid (DOPAC) and the rat mesolimbic dopaminergic pathway: drug effects and evidence for somatodendritic mechanisms.
Beart PM; Gundlach AL
Br J Pharmacol; 1980 Jun; 69(2):241-7. PubMed ID: 6108139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
